Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Cardiopulmonary Resuscitation III: AED Use01:23

Cardiopulmonary Resuscitation III: AED Use

Introduction to AEDAn Automated External Defibrillator (AED) is a portable medical device that analyzes the heart's rhythm and, if necessary, delivers an electrical shock to help the heart re-establish an effective rhythm during sudden cardiac arrest (SCA). SCA occurs when the heart suddenly and unexpectedly stops beating, leading to a loss of blood flow to the brain and other vital organs. In such emergencies, time is of the essence, and using an AED, combined with Cardiopulmonary...
Cardiopulmonary Resuscitation IV: Pharmacological Management01:25

Cardiopulmonary Resuscitation IV: Pharmacological Management

Pharmacologic intervention is crucial in treating cardiac arrest patients during ACLS or Advanced Cardiovascular Life Support. The ACLS algorithms guide the administration of specific drugs based on the patient's cardiac arrest rhythm, which includes pulseless ventricular tachycardia (VT), ventricular fibrillation (VF), asystole, and pulseless electrical activity (PEA).EpinephrineIndication: Epinephrine is the first-line drug for all cardiac arrest rhythms.Mechanism of Action: Epinephrine...
Dysrhythmias VI: Management of Dysrhythmias01:25

Dysrhythmias VI: Management of Dysrhythmias

Dysrhythmia management involves a multifaceted approach, incorporating pharmacological treatments, medical procedures, surgical interventions, lifestyle modifications, and patient education.Pharmacological ManagementAntiarrhythmic Drugs:Class I (Sodium Channel Blockers): This class includes quinidine and procainamide, which reduce the speed of impulse conduction in the heart, stabilize the cardiac membrane, and control arrhythmias. Quinidine and procainamide are Class IA agents that prolong the...
ECG Interpretation of Arrhythmias II: Atrial, Junctional and Ventricular Arrhythmias01:25

ECG Interpretation of Arrhythmias II: Atrial, Junctional and Ventricular Arrhythmias

Arrhythmia is a condition characterized by an irregular heart rhythm, with ECG changes that differ based on its origin and nature. The types of arrhythmias discussed below include atrial, junctional, and ventricular arrhythmias.Atrial ArrhythmiasPremature Atrial Complexes (PACs): PACs are early atrial beats caused by stress, caffeine, alcohol, electrolyte imbalances, hypoxia, hyperthyroidism, or certain medications (e.g., bronchodilators and decongestants). The ECG shows early P waves with an...
Disturbances in Heart Rhythm01:29

Disturbances in Heart Rhythm

Arrhythmia or dysrhythmia refers to an abnormal heart rhythm caused by a defect in the heart's conduction system. It can cause the heart to beat irregularly, too quickly, or too slowly, leading to symptoms like chest pain, shortness of breath, and fainting. Factors such as stress, caffeine, alcohol, nicotine, cocaine, certain drugs, congenital defects, diseases, and electrolyte abnormalities can trigger arrhythmias.
Arrhythmias are categorized by their speed, rhythm, and origin. A slow heart...
Dysrhythmias III: Characteristics of Dysrhythmias01:29

Dysrhythmias III: Characteristics of Dysrhythmias

Dysrhythmias, also known as arrhythmias, are irregular heart rhythms that result from abnormal electrical activity in the heart, affecting its ability to circulate blood efficiently. Tachyarrhythmias, a subset of dysrhythmias, are characterized by abnormally fast heart rates exceeding 100 beats per minute. Here are some types of tachyarrhythmias with their distinct ECG features:Sinus Tachycardia:Sinus tachycardia presents a regular heart rhythm with an increased rate of 101-180 beats per minute.

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Sertraline exposure during development may impact post-myocardial infarction survival in adult mice.

Physiological reports·2025
Same author

Scientific Priorities Related to the Use of Double Sequential External Defibrillation in Patients With Refractory Cardiac Arrest: Report From a Multistakeholder Thinktank.

Journal of the American Heart Association·2025
Same author

Methodology and Conflict of Interest Management: 2025 International Liaison Committee on Resuscitation Consensus on Science With Treatment Recommendations.

Circulation·2025
Same author

Pediatric Life Support: 2025 International Liaison Committee on Resuscitation Consensus on Science With Treatment Recommendations.

Circulation·2025
Same author

Executive Summary: 2025 International Liaison Committee on Resuscitation Consensus on Science With Treatment Recommendations.

Circulation·2025
Same author

Part 3: Ethics: 2025 American Heart Association Guidelines for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care.

Circulation·2025

Related Experiment Video

Updated: Jun 8, 2026

Standardized Model of Ventricular Fibrillation and Advanced Cardiac Life Support in Swine
05:36

Standardized Model of Ventricular Fibrillation and Advanced Cardiac Life Support in Swine

Published on: January 30, 2020

Defibrillation in children.

Sarah E Haskell1, Dianne L Atkins

  • 1Department of Pediatrics, University of Iowa Children's Hospital, University of Iowa Carver College of Medicine, 200 Hawks Drive, Iowa City, IA 52242, USA.

Journal of Emergencies, Trauma, and Shock
|October 9, 2010
PubMed
Summary
This summary is machine-generated.

Optimal pediatric defibrillation techniques are crucial as ventricular fibrillation (VF) occurs in pediatric cardiac arrests. Current research suggests higher energy doses may be more effective and safer for children, improving outcomes.

Keywords:
Defibrillationpediatricsventricular fibrillation

More Related Videos

A Rat Model of Ventricular Fibrillation and Resuscitation by Conventional Closed-chest Technique
09:47

A Rat Model of Ventricular Fibrillation and Resuscitation by Conventional Closed-chest Technique

Published on: April 26, 2015

Related Experiment Videos

Last Updated: Jun 8, 2026

Standardized Model of Ventricular Fibrillation and Advanced Cardiac Life Support in Swine
05:36

Standardized Model of Ventricular Fibrillation and Advanced Cardiac Life Support in Swine

Published on: January 30, 2020

A Rat Model of Ventricular Fibrillation and Resuscitation by Conventional Closed-chest Technique
09:47

A Rat Model of Ventricular Fibrillation and Resuscitation by Conventional Closed-chest Technique

Published on: April 26, 2015

Area of Science:

  • Pediatric Emergency Medicine
  • Cardiology
  • Critical Care

Background:

  • Ventricular fibrillation (VF) is a life-threatening arrhythmia requiring defibrillation.
  • Current pediatric defibrillation guidelines are largely based on adult data.
  • VF is the initial rhythm in 8-20% of pediatric cardiac arrests, highlighting the need for specific pediatric protocols.

Purpose of the Study:

  • To review the history and current literature on pediatric defibrillation.
  • To evaluate optimal energy doses and techniques for defibrillation in children.
  • To identify research gaps and advocate for improved pediatric cardiac arrest care.

Main Methods:

  • Comprehensive literature search using PubMed with MeSH headings: cardiopulmonary resuscitation, defibrillation, and electric countershock.
  • Inclusion of articles from authors' personal bibliographic files.
  • Focus on published articles pertaining to pediatric defibrillation.

Main Results:

  • The historical recommended energy dose for pediatric defibrillation is 2 J/kg.
  • Recent evidence suggests higher doses (e.g., 4 J/kg recommended by the European Resuscitation Council in 2005) may be more effective and safe.
  • Automated external defibrillators show high success rates in pediatric cardiac arrest.

Conclusions:

  • Further research is essential to establish optimal pediatric defibrillation protocols.
  • Standardizing pediatric defibrillation care can improve outcomes for children experiencing cardiac arrest.
  • Evidence supports exploring higher energy doses for improved efficacy and safety in pediatric defibrillation.